ID   PRP4_HUMAN              Reviewed;         522 AA.
AC   O43172; O43445; O43864; Q5T1M8; Q96DG2; Q96IK4;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=U4/U6 small nuclear ribonucleoprotein Prp4;
DE   AltName: Full=PRP4 homolog;
DE            Short=hPrp4;
DE   AltName: Full=U4/U6 snRNP 60 kDa protein;
DE   AltName: Full=WD splicing factor Prp4;
GN   Name=PRPF4; Synonyms=PRP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RX   PubMed=9257651;
RA   Lauber J., Plessel G., Prehn S., Will C.L., Fabrizio P., Groning K.,
RA   Lane W.S., Luehrmann R.;
RT   "The human U4/U6 snRNP contains 60 and 90kD proteins that are
RT   structurally homologous to the yeast splicing factors Prp4p and
RT   Prp3p.";
RL   RNA 3:926-941(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 28-38;
RP   58-85; 95-106; 193-200 AND 457-472, AND INTERACTION WITH U4/U5/U6
RP   SNRNPS.
RX   PubMed=9404889;
RA   Horowitz D.S., Kobayashi R., Krainer A.R.;
RT   "A new cyclophilin and the human homologues of yeast Prp3 and Prp4
RT   form a complex associated with U4/U6 snRNPs.";
RL   RNA 3:1374-1387(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND INTERACTION WITH PRPF3 AND
RP   U4/U5/U6 SNRNPS.
RX   PubMed=9328476; DOI=10.1093/hmg/6.12.2117;
RA   Wang A., Forman-Kay J., Luo Y., Luo M., Chow Y.-H., Plumb J.,
RA   Friesen J.D., Tsui L.-C., Heng H.H.Q., Woolford J.L. Jr., Hu J.;
RT   "Identification and characterization of human genes encoding Hprp3p
RT   and Hprp4p, interacting components of the spliceosome.";
RL   Hum. Mol. Genet. 6:2117-2126(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH PRPF18.
RX   PubMed=9000057; DOI=10.1101/gad.11.1.139;
RA   Horowitz D.S., Krainer A.R.;
RT   "A human protein required for the second step of pre-mRNA splicing is
RT   functionally related to a yeast splicing factor.";
RL   Genes Dev. 11:139-151(1997).
RN   [8]
RP   SUBUNIT.
RX   PubMed=16723661; DOI=10.1261/rna.55406;
RA   Liu S., Rauhut R., Vornlocher H.-P., Luehrmann R.;
RT   "The network of protein-protein interactions within the human U4/U6.U5
RT   tri-snRNP.";
RL   RNA 12:1418-1430(2006).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-27, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 107-137 IN COMPLEX WITH PPIH.
RX   PubMed=12875835; DOI=10.1016/S0022-2836(03)00684-3;
RA   Reidt U., Wahl M.C., Fasshauer D., Horowitz D.S., Luehrmann R.,
RA   Ficner R.;
RT   "Crystal structure of a complex between human spliceosomal cyclophilin
RT   H and a U4/U6 snRNP-60K peptide.";
RL   J. Mol. Biol. 331:45-56(2003).
RN   [12]
RP   INVOLVEMENT IN RP70, AND VARIANT RP70 LEU-315.
RX   PubMed=24419317; DOI=10.1093/hmg/ddu005;
RA   Chen X., Liu Y., Sheng X., Tam P.O., Zhao K., Chen X., Rong W.,
RA   Liu Y., Liu X., Pan X., Chen L.J., Zhao Q., Vollrath D., Pang C.P.,
RA   Zhao C.;
RT   "PRPF4 mutations cause autosomal dominant retinitis pigmentosa.";
RL   Hum. Mol. Genet. 23:2926-2939(2014).
RN   [13]
RP   VARIANT RP70 HIS-192, CHARACTERIZATION OF VARIANT RP70 HIS-192,
RP   INTERACTION WITH PRPF3 AND PPIH, MUTAGENESIS OF ARG-192, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=25383878; DOI=10.1371/journal.pone.0111754;
RA   Linder B., Hirmer A., Gal A., Ruether K., Bolz H.J., Winkler C.,
RA   Laggerbauer B., Fischer U.;
RT   "Identification of a PRPF4 loss-of-function variant that abrogates
RT   U4/U6.U5 tri-snRNP integration and is associated with retinitis
RT   pigmentosa.";
RL   PLoS ONE 9:E111754-E111754(2014).
CC   -!- FUNCTION: Participates in pre-mRNA splicing. Part of the U4/U5/U6
CC       tri-snRNP complex, one of the building blocks of the spliceosome.
CC       {ECO:0000269|PubMed:25383878}.
CC   -!- SUBUNIT: Interacts directly with PRPF18, PPIH and PRPF3. Part of a
CC       heteromeric complex containing PPIH, PRPF3 and PRPF4 that is
CC       stable in the absence of RNA. Component of the U4/U6-U5 tri-snRNP
CC       complex composed of the U4, U6 and U5 snRNAs and at least PRPF3,
CC       PRPF4, PRPF6, PRPF8, PRPF31, SNRNP200, TXNL4A, WDR57, SNRNP40,
CC       DDX23, CD2BP2, PPIH, SNU13, EFTUD2, SART1 and USP39.
CC       {ECO:0000269|PubMed:12875835, ECO:0000269|PubMed:16723661,
CC       ECO:0000269|PubMed:25383878, ECO:0000269|PubMed:9000057,
CC       ECO:0000269|PubMed:9328476, ECO:0000269|PubMed:9404889}.
CC   -!- INTERACTION:
CC       Q92917:GPKOW; NbExp=2; IntAct=EBI-718395, EBI-746309;
CC       O43447:PPIH; NbExp=2; IntAct=EBI-718395, EBI-1055615;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle
CC       {ECO:0000269|PubMed:25383878}. Note=Colocalizes with spliceosomal
CC       snRNPs. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43172-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43172-2; Sequence=VSP_006785;
CC   -!- DISEASE: Retinitis pigmentosa 70 (RP70) [MIM:615922]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:24419317,
CC       ECO:0000269|PubMed:25383878}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF001687; AAB87640.1; -; Genomic_DNA.
DR   EMBL; AF016369; AAC51925.1; -; mRNA.
DR   EMBL; U82756; AAC02261.1; -; mRNA.
DR   EMBL; AL449305; CAI10968.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87362.1; -; Genomic_DNA.
DR   EMBL; BC001588; AAH01588.1; -; mRNA.
DR   EMBL; BC007424; AAH07424.1; -; mRNA.
DR   CCDS; CCDS59142.1; -. [O43172-2]
DR   CCDS; CCDS6791.1; -. [O43172-1]
DR   RefSeq; NP_001231855.1; NM_001244926.1. [O43172-2]
DR   RefSeq; NP_004688.2; NM_004697.4. [O43172-1]
DR   UniGene; Hs.744014; -.
DR   PDB; 1MZW; X-ray; 2.00 A; B=107-137.
DR   PDB; 3JCR; EM; 7.00 A; L=1-522.
DR   PDBsum; 1MZW; -.
DR   PDBsum; 3JCR; -.
DR   ProteinModelPortal; O43172; -.
DR   SMR; O43172; -.
DR   BioGrid; 114576; 133.
DR   IntAct; O43172; 78.
DR   MINT; MINT-270624; -.
DR   STRING; 9606.ENSP00000363313; -.
DR   BindingDB; O43172; -.
DR   ChEMBL; CHEMBL1163119; -.
DR   iPTMnet; O43172; -.
DR   PhosphoSitePlus; O43172; -.
DR   BioMuta; PRPF4; -.
DR   EPD; O43172; -.
DR   MaxQB; O43172; -.
DR   PaxDb; O43172; -.
DR   PeptideAtlas; O43172; -.
DR   PRIDE; O43172; -.
DR   DNASU; 9128; -.
DR   Ensembl; ENST00000374198; ENSP00000363313; ENSG00000136875. [O43172-1]
DR   Ensembl; ENST00000374199; ENSP00000363315; ENSG00000136875. [O43172-2]
DR   GeneID; 9128; -.
DR   KEGG; hsa:9128; -.
DR   UCSC; uc004bgx.4; human. [O43172-1]
DR   CTD; 9128; -.
DR   DisGeNET; 9128; -.
DR   GeneCards; PRPF4; -.
DR   HGNC; HGNC:17349; PRPF4.
DR   HPA; HPA021794; -.
DR   HPA; HPA022248; -.
DR   MalaCards; PRPF4; -.
DR   MIM; 607795; gene.
DR   MIM; 615922; phenotype.
DR   neXtProt; NX_O43172; -.
DR   OpenTargets; ENSG00000136875; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA38448; -.
DR   eggNOG; KOG0272; Eukaryota.
DR   eggNOG; ENOG410XNP8; LUCA.
DR   GeneTree; ENSGT00810000125363; -.
DR   HOGENOM; HOG000157615; -.
DR   HOVERGEN; HBG030892; -.
DR   InParanoid; O43172; -.
DR   KO; K12662; -.
DR   OMA; CWDVRKV; -.
DR   OrthoDB; EOG091G0HXT; -.
DR   PhylomeDB; O43172; -.
DR   TreeFam; TF314922; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SignaLink; O43172; -.
DR   EvolutionaryTrace; O43172; -.
DR   GeneWiki; PRPF4; -.
DR   GenomeRNAi; 9128; -.
DR   PRO; PR:O43172; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000136875; -.
DR   CleanEx; HS_PRPF4; -.
DR   ExpressionAtlas; O43172; baseline and differential.
DR   Genevisible; O43172; HS.
DR   GO; GO:0015030; C:Cajal body; IDA:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005681; C:spliceosomal complex; NAS:UniProtKB.
DR   GO; GO:0097525; C:spliceosomal snRNP complex; IDA:UniProtKB.
DR   GO; GO:0071001; C:U4/U6 snRNP; IDA:UniProtKB.
DR   GO; GO:0046540; C:U4/U6 x U5 tri-snRNP complex; IDA:CAFA.
DR   GO; GO:0030621; F:U4 snRNA binding; IBA:GO_Central.
DR   GO; GO:0017070; F:U6 snRNA binding; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0006396; P:RNA processing; TAS:ProtInc.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   GO; GO:0000375; P:RNA splicing, via transesterification reactions; NAS:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR014906; PRP4-like.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF08799; PRP4; 1.
DR   Pfam; PF00400; WD40; 6.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00500; SFM; 1.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF158230; SSF158230; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 2.
DR   PROSITE; PS50082; WD_REPEATS_2; 6.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; mRNA processing;
KW   mRNA splicing; Nucleus; Reference proteome; Repeat;
KW   Retinitis pigmentosa; Spliceosome; WD repeat.
FT   CHAIN         1    522       U4/U6 small nuclear ribonucleoprotein
FT                                Prp4.
FT                                /FTId=PRO_0000051149.
FT   REPEAT      229    268       WD 1.
FT   REPEAT      271    318       WD 2.
FT   REPEAT      321    360       WD 3.
FT   REPEAT      363    402       WD 4.
FT   REPEAT      405    444       WD 5.
FT   REPEAT      447    487       WD 6.
FT   REPEAT      490    521       WD 7.
FT   MOD_RES      27     27       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ      10     10       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9328476}.
FT                                /FTId=VSP_006785.
FT   VARIANT     192    192       R -> H (in RP70; does not affect nuclear
FT                                speck localization; disrupts interaction
FT                                with PRPF3; does not affect interaction
FT                                with PPIH; does not integrated in
FT                                spliceosomal snRNP complex;
FT                                dbSNP:rs41296057).
FT                                {ECO:0000269|PubMed:25383878}.
FT                                /FTId=VAR_074029.
FT   VARIANT     315    315       P -> L (in RP70; dbSNP:rs587777599).
FT                                {ECO:0000269|PubMed:24419317}.
FT                                /FTId=VAR_071872.
FT   MUTAGEN     192    192       R->E: Decreases PRPF3 binding.
FT                                {ECO:0000269|PubMed:25383878}.
FT   MUTAGEN     192    192       R->K: Decreases PRPF3 binding.
FT                                {ECO:0000269|PubMed:25383878}.
FT   MUTAGEN     192    192       R->W: Decreases PRPF3 binding.
FT                                {ECO:0000269|PubMed:25383878}.
FT   CONFLICT     78    103       HISERQAEVLAEFERRKRARQINVST -> ISASDRQKYWL
FT                                SLREGSEPGRSMFPP (in Ref. 3; AAC02261).
FT                                {ECO:0000305}.
FT   CONFLICT     78     78       H -> R (in Ref. 2; AAC51925).
FT                                {ECO:0000305}.
FT   CONFLICT     86     86       V -> L (in Ref. 1; AAB87640).
FT                                {ECO:0000305}.
FT   CONFLICT    134    134       R -> K (in Ref. 1; AAB87640).
FT                                {ECO:0000305}.
FT   CONFLICT    141    141       G -> D (in Ref. 1; AAB87640).
FT                                {ECO:0000305}.
FT   CONFLICT    176    176       Missing (in Ref. 3; AAC02261).
FT                                {ECO:0000305}.
FT   CONFLICT    275    282       NVGAIVFH -> KKEQLHSI (in Ref. 3;
FT                                AAC02261). {ECO:0000305}.
FT   CONFLICT    405    405       G -> D (in Ref. 1; AAB87640).
FT                                {ECO:0000305}.
FT   CONFLICT    447    447       A -> P (in Ref. 1; AAB87640).
FT                                {ECO:0000305}.
FT   CONFLICT    510    510       C -> Y (in Ref. 1; AAB87640).
FT                                {ECO:0000305}.
FT   CONFLICT    521    521       A -> L (in Ref. 1; AAB87640).
FT                                {ECO:0000305}.
FT   HELIX       108    114       {ECO:0000244|PDB:1MZW}.
FT   STRAND      119    121       {ECO:0000244|PDB:1MZW}.
FT   HELIX       126    136       {ECO:0000244|PDB:1MZW}.
SQ   SEQUENCE   522 AA;  58449 MW;  08975A26D0B21857 CRC64;
     MASSRASSTQ ATKTKAPDDL VAPVVKKPHI YYGSLEEKER ERLAKGESGI LGKDGLKAGI
     EAGNINITSG EVFEIEEHIS ERQAEVLAEF ERRKRARQIN VSTDDSEVKA CLRALGEPIT
     LFGEGPAERR ERLRNILSVV GTDALKKTKK DDEKSKKSKE EYQQTWYHEG PNSLKVARLW
     IANYSLPRAM KRLEEARLHK EIPETTRTSQ MQELHKSLRS LNNFCSQIGD DRPISYCHFS
     PNSKMLATAC WSGLCKLWSV PDCNLLHTLR GHNTNVGAIV FHPKSTVSLD PKDVNLASCA
     ADGSVKLWSL DSDEPVADIE GHTVRVARVM WHPSGRFLGT TCYDRSWRLW DLEAQEEILH
     QEGHSMGVYD IAFHQDGSLA GTGGLDAFGR VWDLRTGRCI MFLEGHLKEI YGINFSPNGY
     HIATGSGDNT CKVWDLRQRR CVYTIPAHQN LVTGVKFEPI HGNFLLTGAY DNTAKIWTHP
     GWSPLKTLAG HEGKVMGLDI SSDGQLIATC SYDRTFKLWM AE
//
